NC
ELV icon

NewSquare Capital’s Elevance Health ELV Stock Holding History

NewSquare Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94
Closed -$36.6K – 490
2025
Q2 		$36.6K Sell
94
-9
-9% -$3.62K ﹤0.01% 339
2025
Q1 		$44.8K Buy
103
+88
+587% +$35.3K ﹤0.01% 248
2024
Q4 		$5.53K Buy
+15
New +$6.28K ﹤0.01% 353
2022
Q1 		– Sell
-28
Closed -$13K – 397
2021
Q4 		$13K Hold
28
– – ﹤0.01% 265
2021
Q3 		$10K Hold
28
– – ﹤0.01% 270
2021
Q2 		$11K Hold
28
– – ﹤0.01% 256
2021
Q1 		$10K Hold
28
– – ﹤0.01% 230
2020
Q4 		$9K Buy
+28
New +$8.59K ﹤0.01% 239
2019
Q2 		– Sell
-985
Closed -$283K – 351
2019
Q1 		$283K Buy
985
+50
+5% +$14.5K 0.05% 103
2018
Q4 		$246K Buy
+935
New +$257K 0.05% 100

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

NewSquare Capital's ELV Position: Q3 2025 in Review

NewSquare Capital sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 94 shares — an estimated $36.6K sold.

NewSquare Capital first reported a position in ELV in Q4 2018 and held it in 10 quarters. The position peaked at $283K in Q1 2019. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • NewSquare Capital reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 94 Elevance Health shares in Q3 2025, an estimated $36.6K.
  • NewSquare Capital first reported a position in Elevance Health in Q4 2018 and held it in 10 quarters.
  • NewSquare Capital's Elevance Health position peaked at $283K in Q1 2019.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.